BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36523991)

  • 1. High expression of RARG accelerates ovarian cancer progression by regulating cell proliferation.
    Xiu L; Zhao Y; Li N; Zeng J; Liu J; Fu Y; Gao Q; Wu L
    Front Oncol; 2022; 12():1063031. PubMed ID: 36523991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and validation of a novel glycolysis-related gene signature for predicting the prognosis in ovarian cancer.
    Yu J; Liu TT; Liang LL; Liu J; Cai HQ; Zeng J; Wang TT; Li J; Xiu L; Li N; Wu LY
    Cancer Cell Int; 2021 Jul; 21(1):353. PubMed ID: 34229669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
    Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
    J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCNB1, Negatively Regulated by miR-559, Promotes the Proliferation, Migration, and Invasion of Ovarian Carcinoma Cells.
    Yang X; Zhou S; Yang C; Cao C; He M; Zi S
    Mol Biotechnol; 2022 Sep; 64(9):958-969. PubMed ID: 35262876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationships between decreased LAMC3 and poor prognosis in ovarian cancer].
    Lei SM; Liu X; Xia LP; Ke Y; Wei LW; Li L; Yin FJ
    Zhonghua Fu Chan Ke Za Zhi; 2021 Jul; 56(7):489-497. PubMed ID: 34304441
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic Significance and Related Mechanisms of Hexokinase 1 in Ovarian Cancer.
    Li Y; Tian H; Luo H; Fu J; Jiao Y; Li Y
    Onco Targets Ther; 2020; 13():11583-11594. PubMed ID: 33204111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TCP1 regulates PI3K/AKT/mTOR signaling pathway to promote proliferation of ovarian cancer cells.
    Weng H; Feng X; Lan Y; Zheng Z
    J Ovarian Res; 2021 Jun; 14(1):82. PubMed ID: 34162426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. F-Box and Leucine-Rich Repeat Protein 20 (FBXL20), Negatively Regulated by microRNA (miR)-195-5p, Accelerates the Malignant Progression of Ovarian Cancer.
    Wu D; Liu C; Hong L
    Mol Biotechnol; 2021 Dec; 63(12):1235-1243. PubMed ID: 34338995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [High expression of MYBL2 promotes progression and predicts a poor survival outcome of prostate cancer].
    Yang M; Zhu X; Shen Y; He Q; Qin Y; Shao Y; Yuan L; Ye H
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Aug; 42(8):1109-1118. PubMed ID: 36073208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KDF1 Promoted Proliferation and Metastasis of Epithelial Ovarian Cancer
    Zhu C; Liu Y; Tong R; Guan J
    Front Genet; 2022; 13():808100. PubMed ID: 35281796
    [No Abstract]   [Full Text] [Related]  

  • 11. High expression of TRIM24 predicts worse prognosis and promotes proliferation and metastasis of epithelial ovarian cancer.
    Zhang L; Chen H; Ding B; Jiang W
    J Ovarian Res; 2022 Feb; 15(1):19. PubMed ID: 35105347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoic acid receptor gamma is required for proliferation of pancreatic cancer cells.
    Ji K; Dou W; Zhang N; Wen B; Zhong M; Zhang Q; Xu S; Zhou J; Liu J
    Cell Biol Int; 2023 Jan; 47(1):144-155. PubMed ID: 36183362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological and prognostic value of ETV5 in high-grade serous ovarian cancer.
    Zhang L; Fu R; Liu P; Wang L; Liang W; Zou H; Jia W; Tao L
    J Ovarian Res; 2021 Nov; 14(1):149. PubMed ID: 34736492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-testis antigen ACRBP expression and serum immunoreactivity in ovarian cancer: Its association with prognosis.
    Lin L; Nong W; Luo B; Ge Y; Zeng X; Li F; Fan R; Zhang Q; Xie X
    Immun Inflamm Dis; 2021 Dec; 9(4):1759-1770. PubMed ID: 34528758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PDP1 Promotes Cell Malignant Behavior and Is Associated with Worse Clinical Features in Ovarian Cancer Patients: Evidence from Bioinformatics and In Vitro Level.
    Song Y; Zhang J; Zhang L; Zhang S; Shen C
    Comput Math Methods Med; 2022; 2022():7397250. PubMed ID: 36276992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of SPINK13 Promotes Metastasis by Regulating uPA in Ovarian Cancer Cells.
    Cai S; Zhang P; Dong S; Li L; Cai J; Xu M
    Cell Physiol Biochem; 2018; 45(3):1061-1071. PubMed ID: 29439245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
    Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
    Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
    [No Abstract]   [Full Text] [Related]  

  • 18. Overexpression of RIPK4 Predicts Poor Prognosis and Promotes Metastasis in Ovarian Cancer.
    Liu S; He L; Sheng C; Su R; Wu X; Sun Y; Xi X
    Biomed Res Int; 2021; 2021():6622439. PubMed ID: 34124253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA GIHCG promotes development of ovarian cancer by regulating microRNA-429.
    Yao N; Yu L; Zhu B; Gan HY; Guo BQ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8127-8134. PubMed ID: 30556850
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Guo W; Sun Z; Zhao N; Zhou Y; Ren J; Huang L; Ping Y
    Ann Transl Med; 2021 Nov; 9(22):1669. PubMed ID: 34988178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.